Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Linezolid resistant coagulase negative staphylococci (LRCoNS) with novel mutations causing blood stream infections (BSI) in India

14 Aug 2019

Abstract excerpt

BACKGROUND: Coagulase-negative Staphylococci (CoNS) have emerged as a major causative agent of blood-stream infections (BSI). Linezolid (LZD) is currently used for treating glycopeptide and methicillin-resistant staphylococci. It is important to understand the resistance mechanism and probable transmission of LZD resistant (LR) CoNS within the hospital. METHODS: Clinically significant LRCoNS from patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Neonatal and Maternal Infections
Share to Streptococcal Infections and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31412801
DOI: 10.1186/s12879-019-4368-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Linezolid resistant coagulase negative staphylococci (LRCoNS) with novel mutations causing blood stream infections (BSI) in IndiaPMID 31412801Read ↗

A cfr-positive clinical staphylococcal isolate from India with multiple mechanisms of linezolid-resistance.Semantic proximity Read ↗

Coagulase-negative staphylococci causing blood stream infection at an Indian tertiary care hospital: Prevalence, antimicrobial resistance and molecular characterisation.Semantic proximity Read ↗

Characterization of linezolid- and methicillin-resistant coagulase-negative staphylococci in a tertiary hospital in China.Semantic proximity Read ↗

Global Expansion of Linezolid-Resistant Coagulase-Negative StaphylococciSemantic proximity Read ↗

Mechanisms of Linezolid Resistance among Coagulase-Negative Staphylococci Determined by Whole-Genome SequencingSemantic proximity Read ↗

Prevalence and Molecular Determinants of Antimicrobial Resistance in Clinical Isolates of Staphylococcus haemolyticus from IndiaSemantic proximity Read ↗

Prevalence and mechanisms of linezolid resistance among staphylococcal clinical isolates from EgyptSemantic proximity Read ↗

Characterization of linezolid- and methicillin-resistant coagulase-negative staphylococci in a tertiary hospital in ChinaSemantic proximity Read ↗

The emerging problem of linezolid-resistant <i>Staphylococcus</i>Semantic proximity Read ↗

Update on Coagulase-Negative Staphylococci—What the Clinician Should KnowSemantic proximity Read ↗

Novel Domain V mutation in<i>cfr</i>-positive clinical<i>Staphylococcus haemolyticus</i>isolates causing linezolid resistance in Egyptian ICU patientsSemantic proximity Read ↗

Emergence of linezolid-resistant Staphylococcus epidermidis in the tertiary children’s hospital in Cracow, PolandSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.